Recognition and treatment of depressive symptoms in Parkinson's disease: The NPF dataset

Danny Bega*, Sam S. Wu, Qinglin Pei, Peter N. Schmidt, Tanya Simuni

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Depression is a major determinant of Health Related Quality of Life in PD, but there is limited data on physician recognition of depression and treatment efficacy. We used data obtained from the QII dataset of the National Parkinson's Foundation database to determine whether there was an association between depressive symptoms and utilization of antidepressants and/or mental health services (MHS) in a large cohort of PD patients. We found that prevalence of depressive symptoms remained high in the PD population despite improved physician recognition and treatment initiation.

Original languageEnglish (US)
Pages (from-to)639-643
Number of pages5
JournalJournal of Parkinson's disease
Volume4
Issue number4
DOIs
StatePublished - 2014

Keywords

  • NPF
  • Parkinson's disease
  • depression

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Recognition and treatment of depressive symptoms in Parkinson's disease: The NPF dataset'. Together they form a unique fingerprint.

Cite this